Header image

Oral Presentations 18: Respiratory and Inflammation 2

Tracks
Track 2
Wednesday, July 15, 2026
9:00 AM - 10:30 AM

Speaker

Agenda Item Image
Ms Liv Young
Monash University

AT2R agonists inhibit ECM production in an ex-vivo model of IPF-like fibrogenesis

Abstract

Biography

Olivia Young is a researcher and member of the Bourke Lab within the Monash University Discovery Institute. Her work, likely within the Faculty of Medicine, Nursing and Health Sciences, focuses on areas within the biomedical or biological sciences, collaborating within a team specializing in chronic disease research.
Agenda Item Image
Prof Jian Gao
Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University

Cordycepin ameliorates pulmonary fibrosis by targeting HDAC7 to suppress epithelial-mesenchymal transition

Abstract

Biography

Agenda Item Image
Miss Elaine Koh
The University Of Melbourne

Fibroblast growth factor 2 in modulating Nintedanibs anti-fibrogenic efficacy in pulmonary fibroblasts

Abstract

Biography

Agenda Item Image
Mr Avanka Gunatilaka
University Of Melbourne

CXCL17 augments inflammatory signalling by PolyI:C in human airway epithelial basal cells

Abstract

Biography

Agenda Item Image
Mr Will Studley
Monash University

Vascular remodelling in an ex vivo lung model of pulmonary arterial hypertension

Abstract

Biography

William Studley is a Biomedical Scientist and PhD student within the Department of Pharmacology at Monash University. Based in the Bourke Lab at the Monash Biomedicine Discovery Institute, his research focuses on pharmacological studies. He has contributed to research regarding small-molecule formyl peptide receptor agonists.
Agenda Item Image
Prof Jian Gao
Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University

Metformin ameliorates pulmonary fibrosis by inhibiting autophagy via AMPK/FoxO3a pathway

Abstract

Biography

loading